Lenalidomide normalizes tumor vessels in colorectal cancer improving chemotherapy activity

BACKGROUND: Angiogenesis inhibition is a promising approach for treating metastatic colorectal cancer (mCRC). Recent evidences support the seemingly counterintuitive ability of certain antiangiogenic drugs to promote normalization of residual tumor vessels with important clinical implications. Lenal...

Descripción completa

Detalles Bibliográficos
Autores principales: Leuci, V., Maione, F., Rotolo, R., Giraudo, E., Sassi, F., Migliardi, G., Todorovic, M., Gammaitoni, L., Mesiano, G., Giraudo, L., Luraghi, P., Leone, F., Bussolino, F., Grignani, G., Aglietta, M., Trusolino, L., Bertotti, A., Sangiolo, D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4857418/
https://www.ncbi.nlm.nih.gov/pubmed/27149858
http://dx.doi.org/10.1186/s12967-016-0872-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4857418/
https://www.ncbi.nlm.nih.gov/pubmed/27149858
http://dx.doi.org/10.1186/s12967-016-0872-2

Ejemplares similares